GENEVA, Oct. 20 -- FOUNDATION MEDICINE, INC. (400 Summer StreetBoston, Massachusetts 02210) filed a patent application (PCT/US2025/024282) for "CLONAL NEOANTIGEN BURDEN AS A BIOMARKER OF IMMUNOTHERAPY RESPONSE" on Apr 11, 2025. With publication no. WO/2025/217519, the details related to the patent application was published on Oct 16, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MONTESION, Meagan Kathleen (c/o Foundation Medicine, Inc.400 Summer StreetBoston, Massachusetts 02210), MURUGESAN, Karthikeyan (c/o Foundation Medicine, Inc.400 Summer StreetBoston, Massachusetts 02210), JIN, Dexte...